GP KFPs / SAQs · musculoskeletal-presentations
Knee osteoarthritis — KFP-style written assessment
KFP-style staged scenarios on knee and hip osteoarthritis: clinical diagnosis without imaging, core treatments with quantified effects, the topical-first drug ladder, retired treatments, intra-articular steroid expectations, and arthroplasty referral without BMI gates.
On this page
Study tools
Target exams
RACGP KFPRACGP AKTMRCGP AKT
Prompt
Knee osteoarthritis: diagnose clinically, treat the core, prescribe topically, refer on need
KFP 1 (10 marks)
A 61-year-old postman presents with six months of right knee pain on his delivery round. Morning stiffness lasts 20 minutes and eases with movement. Examination shows bony swelling, crepitus, no effusion, stable ligaments, full extension. BMI 31. He requests an X-ray "to see how bad it is". [8]
- State your diagnosis pathway with the specific clinical criteria, and what you tell him about imaging. (3) [8]
- Outline the core treatments with quantified expected benefit. (4) [1][2][8]
- He asks for painkillers. Give the first-line drug, its trial basis, and what you will not prescribe routinely. (3) [3][4]
Model answers
- Diagnose OA clinically without imaging: he is over 45, has activity-related joint pain, and morning stiffness under 30 minutes. Explain that OA is diagnosed clinically, imaging is not needed to confirm it unless atypical features emerge, and management is guided by symptoms and physical function. [8]
- Core treatments: therapeutic exercise (Cochrane high-quality evidence: pain reduced ~12 points on 100-point scale, SMD −0.49; function ~10 points; comparable with NSAIDs) and weight management — advise that any weight loss helps but 10% of body weight beats 5% (IDEA achieved 11.4% mean loss with diet+exercise, less pain, better function; dose-response shows 10–19.9% loss is substantially better). Add walking stick if helpful, education and self-management. [1][2][8]
- Offer topical NSAID first (NNT 9.8 for diclofenac clinical success; similar efficacy to oral without systemic toxicity). Do not routinely offer paracetamol (Cochrane: no clinically important improvement, ~3 points vs MCID 9) or weak opioids. [3][4]
References8ShowHide
- [1]Fransen M et al. Exercise for osteoarthritis of the knee. The Cochrane database of systematic reviews, 2015.PMID 25569281
- [2]Messier SP et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA, 2013.PMID 24065013
- [3]Derry S et al. Topical NSAIDs for chronic musculoskeletal pain in adults. The Cochrane database of systematic reviews, 2016.PMID 27103611
- [4]Leopoldino AO et al. Paracetamol versus placebo for knee and hip osteoarthritis. Annals of the rheumatic diseases, 2019.PMID 30801133
- [5]Kolasinski SL et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & rheumatology (Hoboken, N.J.), 2020.PMID 31908163
- [6]Bensa A et al. Intra-articular corticosteroid injections provide a clinically relevant benefit compared to placebo only at short-term follow-up in patients with knee osteoarthritis: A systematic review and meta-analysis. Knee surgery, sports traumatology, arthroscopy, 2024.PMID 38294103
- [7]Sihvonen R et al. Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. The New England journal of medicine, 2013.PMID 24369076
- [8]Messier SP et al. Intentional Weight Loss in Overweight and Obese Patients With Knee Osteoarthritis: Is More Better? Arthritis care & research, 2018.PMID 29911741